Najeeb Ali is a founding member of the MedTech practice at Centerview Partners. He has 20 years of experience as a strategic advisor to healthcare companies across medical device, life sciences/diagnostics, specialty pharma, and services sectors. Over the course of his career, Mr. Ali has engaged with clients on a broad range of complex strategic transactions, spin-offs and carve-outs, buy-side and sell-side mergers and acquisitions, divestitures, special committee assignments, debt and equity financings, and partnerships.
Select experience includes:
Medical Device and LS/DxMasimo on its announced strategic alternatives for Consumer Audio and Consumer Healthcare businesses
Special Committee of the Board of Masimo in connection with its evaluation of certain strategic alternatives
Illumina on 85.5% Spin-off of Grail and advisor to Illumina on its proxy fight with Carl Icahn
ZimVie on the $375 million sale of its spine business to HIG Capital
Teleflex on its $600 million acquisition of Palette Life Sciences
BK Medical on its $1.5 billion sale to GE
Wright Medical on its $5.4 billion sale to Stryker
Zimmer Biomet on its Spin-off of ZimVie
Danaher on its carve-out IPO and Split-off of Envista
Envista on its $600 million acquisition of Carestream Dental’s intra-oral scanner business from Clayton, Dubilier & Rice and on $455 million sale of its KaVo business to Planmeca
Enovis (formerly Colfax) on its $3.2 billion acquisition of DJO Global from Blackstone
Covidien on its Spin-off of Mallinckrodt
Specialty Pharma
Amneal on its $6.4 billion merger with Impax Labs
Altaris Capital on its $1.6 billion acquisition of Padagis, formerly Perrigo’s generic prescription pharmaceuticals division
Par Pharmaceuticals on its $1.9 billion sale to TPG and subsequent $8.1 billion sale to Endo International
Gavis Pharmaceuticals on its $900 million sale to Lupin
Healthcare Services
Cardinal Health on its $1.0 billion sale of Cordis business to Hellman & Friedman
Blackstone, Carlyle, and Hellman & Friedman on its $34 billion acquisition of Medline Industries
PharMEDium on its $2.6 billion sale to AmerisourceBergen
Prior to joining Centerview in 2022, Mr. Ali spent 18 years at J.P. Morgan, most recently as a Managing Director within its Healthcare business. Mr. Ali received his Bachelor of Science and a Master of Business Administration in Finance from Kelley School of Business at Indiana University Bloomington.